U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 16:23:19 GMT 2023
Edited
by admin
on Sat Dec 16 16:23:19 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
CXX4Q31AAO
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EBRONUCIMAB
INN  
Official Name English
Ebronucimab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(HOMO SAPIENS PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEIN CONVERTASE 9, PC9)), HOMO SAPIENS MONOCLONAL ANTIBODY
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEURAL APOPTOSIS-REGULATED CONVERTASE 1) (HUMAN MONOCLONAL AK102 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AK102 .LAMBDA.-CHAIN, DIMER
Common Name English
ebronucimab [INN]
Common Name English
Code System Code Type Description
INN
11476
Created by admin on Sat Dec 16 16:23:20 GMT 2023 , Edited by admin on Sat Dec 16 16:23:20 GMT 2023
PRIMARY
NCI_THESAURUS
C175774
Created by admin on Sat Dec 16 16:23:20 GMT 2023 , Edited by admin on Sat Dec 16 16:23:20 GMT 2023
PRIMARY
FDA UNII
CXX4Q31AAO
Created by admin on Sat Dec 16 16:23:20 GMT 2023 , Edited by admin on Sat Dec 16 16:23:20 GMT 2023
PRIMARY
CAS
2304800-90-4
Created by admin on Sat Dec 16 16:23:20 GMT 2023 , Edited by admin on Sat Dec 16 16:23:20 GMT 2023
PRIMARY
From To
4_139 4_198
4_22 4_90
3_139 3_198
3_22 3_90
2_373 2_431
2_267 2_327
2_226 4_216
2_150 2_206
2_22 2_96
1_373 1_431
1_267 1_327
1_235 2_235
1_232 2_232
1_226 3_216
1_150 1_206
1_22 1_96
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_303
N 2_303
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Antihypercholesterolemic
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL